Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SI-6603 in Lumbar Disc Herniation
NCT01941563Phase 3Completed
- Sponsor
- Seikagaku Corporation
- Start
- Sep 2013
- Primary completion
- Nov 2015
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of condoliase in lumbar disc herniation (LDH), sponsored by Seikagaku Corporation. Started Sep 2013; status: completed.
02
Drugs
condoliase
03
Conditions
lumbar disc herniation (LDH)
Beyond the preview
Go deeper on NCT01941563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01941563.